Mo. Woman Says Weight Loss Supplement Fastin Caused Cardiovascular Events

DETROIT — A Missouri woman is suing Hi-Tech Pharmaceuticals Inc., alleging that it failed to warn doctors and consumers that its weight loss supplement Fastin can cause cardiovascular events.

In an Oct. 9 complaint filed in the U.S. District Court for the Eastern District of Missouri, Linda Cagle claims that Fastin contained dimethylamylamine (DMAA), a synthetic ingredient which is known to narrow blood vessels and arteries, leading to cardiovascular events ranging from shortness of breath to heart attack.

According to the filing, Linda Cagle took Fastin for 12 days in October 2009, after which she experienced shortness of breath and …